Remyelination alters the pattern of myelin in the cerebral cortex.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
27 05 2020
Historique:
received: 04 03 2020
accepted: 22 05 2020
pubmed: 28 5 2020
medline: 16 3 2021
entrez: 28 5 2020
Statut: epublish

Résumé

Destruction of oligodendrocytes and myelin sheaths in cortical gray matter profoundly alters neural activity and is associated with cognitive disability in multiple sclerosis (MS). Myelin can be restored by regenerating oligodendrocytes from resident progenitors; however, it is not known whether regeneration restores the complex myelination patterns in cortical circuits. Here, we performed time lapse in vivo two photon imaging in somatosensory cortex of adult mice to define the kinetics and specificity of myelin regeneration after acute oligodendrocyte ablation. These longitudinal studies revealed that the pattern of myelination in cortex changed dramatically after regeneration, as new oligodendrocytes were formed in different locations and new sheaths were often established along axon segments previously lacking myelin. Despite the dramatic increase in axonal territory available, oligodendrogenesis was persistently impaired in deeper cortical layers that experienced higher gliosis. Repeated reorganization of myelin patterns in MS may alter circuit function and contribute to cognitive decline.

Identifiants

pubmed: 32459173
doi: 10.7554/eLife.56621
pii: 56621
pmc: PMC7292648
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : P30 NS050274
Pays : United States
Organisme : NIH HHS
ID : NS080153
Pays : United States
Organisme : NIH HHS
ID : NS051509
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS091018
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS041435
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS041435
Pays : United States
Organisme : NIH HHS
ID : NS050274
Pays : United States

Informations de copyright

© 2020, Orthmann-Murphy et al.

Déclaration de conflit d'intérêts

JO, CC, GM, YH, MR No competing interests declared, PC PI on grants to JHU from Biogen and Annexon and has received consulting fees for serving on scientific advisory boards for Biogen and Disarm Therapeutics. 1147, DB Reviewing editor, eLife

Références

Brain. 2006 Dec;129(Pt 12):3186-95
pubmed: 16766541
J Neurosci. 2006 Jan 4;26(1):328-32
pubmed: 16399703
Cell Stem Cell. 2011 Nov 4;9(5):402-11
pubmed: 22056138
AJNR Am J Neuroradiol. 2013 Apr;34(4):791-6
pubmed: 23042930
Curr Biol. 2018 Feb 19;28(4):549-559.e3
pubmed: 29429620
Bioinformatics. 2011 Sep 1;27(17):2453-4
pubmed: 21727141
J Neurosci. 2008 Oct 8;28(41):10434-42
pubmed: 18842903
Nat Neurosci. 2013 May;16(5):571-9
pubmed: 23542689
Science. 2014 Apr 18;344(6181):319-24
pubmed: 24744380
J Neurosci. 2019 Mar 20;39(12):2184-2194
pubmed: 30696729
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
Neurology. 2019 Mar 12;92(11):519-533
pubmed: 30787160
Elife. 2016 Sep 27;5:
pubmed: 27671734
Science. 2014 Oct 17;346(6207):318-22
pubmed: 25324381
Cold Spring Harb Protoc. 2012 Jun 01;2012(6):694-701
pubmed: 22661440
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9030-9039
pubmed: 30910981
Nat Neurosci. 2016 Sep;19(9):1210-1217
pubmed: 27455109
Elife. 2016 Jul 06;5:
pubmed: 27383052
Brain. 2008 Dec;131(Pt 12):3286-98
pubmed: 18927145
Brain. 1999 Jan;122 ( Pt 1):17-26
pubmed: 10050891
J Neurosci Res. 2007 Aug 1;85(10):2080-6
pubmed: 17492793
Annu Rev Cell Dev Biol. 2015;31:699-720
pubmed: 26359774
Cell. 2014 Nov 6;159(4):766-74
pubmed: 25417154
Cereb Cortex. 2017 Oct 1;27(10):5001-5013
pubmed: 28922832
J Neurocytol. 1995 Oct;24(10):775-81
pubmed: 8586997
Brain. 2007 Apr;130(Pt 4):1089-104
pubmed: 17438020
Nature. 2011 Mar 10;471(7337):177-82
pubmed: 21390124
Nat Neurosci. 2017 Jan;20(1):10-15
pubmed: 27775720
J Neurotrauma. 2011 Jun;28(6):1089-100
pubmed: 21309692
Brain Pathol. 2001 Jan;11(1):107-16
pubmed: 11145196
Acta Neuropathol. 2010 May;119(5):579-89
pubmed: 20091409
Nat Neurosci. 2013 Sep;16(9):1211-1218
pubmed: 23872599
Am J Pathol. 2008 Apr;172(4):1053-61
pubmed: 18349131
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):60-6
pubmed: 23813636
Neuron. 2010 Nov 18;68(4):668-81
pubmed: 21092857
Cell Stem Cell. 2012 Jan 6;10(1):96-103
pubmed: 22226359
Mol Psychiatry. 2017 Jan;22(1):4-12
pubmed: 27646261
Nature. 2019 Feb;566(7745):538-542
pubmed: 30675058
Nat Neurosci. 2013 Jun;16(6):668-76
pubmed: 23624515
Curr Neuropharmacol. 2019;17(2):129-141
pubmed: 28714395
Nat Med. 2014 Aug;20(8):954-960
pubmed: 24997607
Mult Scler. 2019 Aug 1;:1352458519867320
pubmed: 31368404
Nat Neurosci. 2018 May;21(5):696-706
pubmed: 29556025
Glia. 2010 Jun;58(8):964-74
pubmed: 20169621
Glia. 2017 Dec;65(12):2087-2098
pubmed: 28940645
Elife. 2018 Jul 06;7:
pubmed: 29979149
Science. 2014 May 2;344(6183):1252304
pubmed: 24727982
Exp Neurol. 2016 Sep;283(Pt B):446-51
pubmed: 26775177
Brain. 2011 Sep;134(Pt 9):2755-71
pubmed: 21840891
J Neuropathol Exp Neurol. 2017 Feb 08;76(2):109-125
pubmed: 28177496
Nature. 2015 Oct 15;526(7573):448-52
pubmed: 26416758
Neuroscience. 2014 Sep 12;276:2-13
pubmed: 25003711
AJNR Am J Neuroradiol. 2018 Mar;39(3):459-466
pubmed: 29439120
Dev Cell. 2013 Jun 24;25(6):599-609
pubmed: 23806617
Neuron Glia Biol. 2004 Aug;1(3):179-92
pubmed: 18634596
Ann Neurol. 2012 Dec;72(6):918-26
pubmed: 23076662
J Neuroinflammation. 2017 Aug 18;14(1):162
pubmed: 28821276
Nat Neurosci. 2020 May 18;:
pubmed: 32424285
Mult Scler. 1997 Apr;3(2):133-6
pubmed: 9291167
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6777-80
pubmed: 2168559
Immunity. 2020 Jan 14;52(1):167-182.e7
pubmed: 31883839
J Vis Exp. 2014 Apr 12;(86):
pubmed: 24747942
J Neurosci. 2000 Sep 1;20(17):6404-12
pubmed: 10964946
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8168-73
pubmed: 15148385
Dev Cell. 2019 Dec 16;51(6):730-744.e6
pubmed: 31761670
Nat Med. 2005 Sep;11(9):966-72
pubmed: 16086023
Nature. 2013 Oct 17;502(7471):327-332
pubmed: 24107995
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1299-304
pubmed: 22160722
Nat Commun. 2019 Aug 29;10(1):3887
pubmed: 31467299
N Engl J Med. 2011 Dec 8;365(23):2188-97
pubmed: 22150037
Brain Res. 2009 Aug 4;1283:127-38
pubmed: 19524552
Neuron. 2013 Mar 6;77(5):873-85
pubmed: 23473318
Neurology. 2013 Aug 13;81(7):641-9
pubmed: 23864311
Brain. 2012 Oct;135(Pt 10):2952-61
pubmed: 23065788
Brain Pathol. 2018 Sep;28(5):735-742
pubmed: 30020563
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):11832-11837
pubmed: 30373833
Cell Stem Cell. 2019 Oct 3;25(4):473-485.e8
pubmed: 31585093
Ann Neurol. 2012 Sep;72(3):419-32
pubmed: 23034914
Nat Neurosci. 2005 Jun;8(6):745-51
pubmed: 15895088
Nat Neurosci. 2018 May;21(5):683-695
pubmed: 29556031
J Cell Biol. 1997 Apr 21;137(2):459-68
pubmed: 9128255
J Neurosci. 2015 Jun 3;35(22):8626-39
pubmed: 26041928

Auteurs

Jennifer Orthmann-Murphy (J)

The Solomon Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, United States.
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.

Cody L Call (CL)

The Solomon Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, United States.

Gian C Molina-Castro (GC)

The Solomon Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, United States.

Yu Chen Hsieh (YC)

The Solomon Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, United States.

Matthew N Rasband (MN)

Department of Neuroscience, Baylor College of Medicine, One Baylor Plaza, Houston, United States.

Peter A Calabresi (PA)

Department of Neurology Johns Hopkins University, Baltimore, United States.

Dwight E Bergles (DE)

The Solomon Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, United States.
Johns Hopkins University Kavli Neuroscience Discovery Institute, Baltimore, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH